HBI Deals+Insights / News
CNX Therapeutics, a European specialty pharmaceutical company, has acquired the global rights to Sativex (nabiximols), an oral spray used to treat muscle stiffness and spasms in adults with multiple sclerosis, from Jazz Pharmaceuticals, a US-based biopharmaceutical company focused on oncology and neuroscience. Guy Clark, CEO of CNX Therapeutics, tells HBI the deal strengthens the company’s […]





